This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Alzheimer's Disease Therapeutics: Alternatives to Amyloid 2019

Alzheimer's Disease Therapeutics: Alternatives to Amyloid 2019

Wednesday, November 20, 2019, 8:30 AM - 5:30 PM

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

Brain and Behavior Discussion Group

The New York Academy of Sciences


For the last 25 years, research in Alzheimer’s disease has focused on amyloid as the key driver of disease pathogenesis. However, the recent failure of several Phase III clinical trials targeting amyloid has reinforced the need to critically evaluate these trials and consider different approaches.  There is burgeoning interest in identifying alternative drug targets: over half of ongoing preclinical research in Alzheimer’s disease now focuses on neuro-inflammation, bioenergetics, epigenetics, protein homeostasis and other alternative pathways.

This conference will consider the landscape of Alzheimer’s disease research including the current state of the amyloid hypothesis, emerging disease mechanisms, and strategies to develop novel therapeutic approaches.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Friday, September 20, 2019.


By 10/11/2019
After 10/11/2019
Nonmember Academia, Faculty, etc.
By 10/11/2019
After 10/11/2019
Nonmember Corporate, Other
By 10/11/2019
After 10/11/2019
Nonmember Not for Profit
By 10/11/2019
After 10/11/2019
Nonmember Student, Undergrad, Grad, Fellow
By 10/11/2019
After 10/11/2019
Member Student, Post-Doc, Fellow
By 10/11/2019
After 10/11/2019

Scientific Organizing Committee

Howard Fillit, MD

Alzheimer's Drug Discovery Foundation

Rudolph Tanzi, PhD

Harvard Medical School

George Zavoico, PhD

B. Riley FBR

Sara Donnelly, PhD

The New York Academy of Sciences

Amanda Sadacca, PhD

The New York Academy of Sciences


David Holtzman, MD

Washington University School of Medicine

Roberta Brinton, PhD

University of Arizona

Cheryl Wellington, PhD

University of British Columbia

Joel Dudley, PhD

Icahn School of Medicine at Mount Sinai

Sangram Sisodia, PhD

University of Chicago

Manolis Kellis, PhD

Massachusetts Institute of Technology